Biotechnology

A novel drug is in clinical trials for depression, moving beyond neurotransmitters to target the brain's fundamental energy production and repair mechanisms.

ZoomRx's new AI operating system, Sagan Agents, promises to slash market research timelines from weeks to days, reshaping strategic insights for biopharma.

Massachusetts has approved a groundbreaking on-site technology that turns hazardous medical waste into recyclable material, disrupting the traditional disposal industry.

A new partnership embeds Eli Lilly's powerful AI models into CDD Vault, giving smaller biotechs unprecedented access to big pharma's discovery tools.

A new clinical trial is testing a device that uses electricity to deliver chemo directly into tumors, a strategy that could revolutionize treatment.

IGI announces ISB 2301, a first-in-class antibody targeting three tumor antigens and activating both T and NK cells for a new assault on solid tumors.

Mispro's new contract vivarium at Genesis Science Center aims to provide crucial, flexible lab space for San Diego's burgeoning biotech startups.

The 12th Annual Ride of Hope adds new challenging routes to honor Terry's legacy, channeling funds into cutting-edge precision cancer research.

A new purpose-built lab, Toronto's first in 20 years, attracts a major cell therapy firm, signaling a turning point for Canada's life sciences sector.

A first-in-class drug for anxiety has entered patient trials, offering a novel approach that could reshape mental healthcare for millions.

Two specialist investors are merging to create the world's largest dedicated healthcare fund, aiming to reshape global health innovation from West to East.

Led by OrbiMed, the financing will propel Accro's promising oral RIPK2 inhibitor for Ulcerative Colitis into a pivotal Phase IIb clinical trial.

A new partnership aims to solve one of biotech's biggest challenges, expanding powerful gene therapies beyond the liver to treat a wider range of diseases.

A biotech firm has hatched healthy chicks from artificial eggs, a breakthrough paving the way for de-extinction and a new era in avian conservation.

New projects leverage AI, gene therapy advances, and diverse workforce initiatives to bolster America's manufacturing and secure its talent pipeline.

Neurovascular giant Balt deepens its Irvine roots with a new facility, a $400M investment, and plans for 700 jobs to accelerate stroke-fighting tech.

Health AI firm Vi secures unicorn status with a $145M deal while launching new AI agents. But can its vision of 'health abundance' overcome ethical hurdles?

Amid global tensions, a Hong Kong summit showcases China's vision for a new world order and the city's bid to remain a vital international hub.

Renowned cancer researcher Dr. Dario Altieri leaves a top CEO post to return to the lab at Jefferson, signaling a major shift in Philadelphia's science scene.

Amplexd Therapeutics launches a Phase 2 trial in Hong Kong for a novel, non-surgical HPV therapy, offering hope to millions in diagnostic limbo.